Procalcitonin levels in acute exacerbation of COPD admitted in ICU: a prospective cohort study.
about
Procalcitonin levels and bacterial aetiology among COPD patients admitted to the ICU with severe pneumonia: a prospective cohort studyProcalcitonin and C-reactive protein cannot differentiate bacterial or viral infection in COPD exacerbation requiring emergency department visits.PCT as a Prognostic Marker in Cardiac Patients with Neutropenic Sepsis: Two Case Reports.Prevalence and risk of viral infection in patients with acute exacerbation of chronic obstructive pulmonary disease: a meta-analysis.Defining exacerbations in chronic obstructive pulmonary disease.The role of viral infections in exacerbations of chronic obstructive pulmonary disease and asthma.Evaluation of new laboratory tests to discriminate bacterial from nonbacterial chronic obstructive pulmonary disease exacerbations.Procalcitonin in patients with influenza A (H1N1) infection and acute respiratory failure.Serum inflammatory biomarkers and clinical outcomes of COPD exacerbation caused by different pathogens.Comparison of diagnostic values of procalcitonin, C-reactive protein and blood neutrophil/lymphocyte ratio levels in predicting bacterial infection in hospitalized patients with acute exacerbations of COPD.Procalcitonin: Is it a predictor of noninvasive positive pressure ventilation necessity in acute chronic obstructive pulmonary disease exacerbation?Procalcitonin, a valuable biomarker assisting clinical decision-making in the management of community-acquired pneumonia.Procalcitonin measurement in routine emergency medicine practice: comparison between two immunoassays.Procalcitonin algorithm to guide initial antibiotic therapy in acute exacerbations of COPD admitted to the ICU: a randomized multicenter study.The Use of Serum Procalcitonin as a Diagnostic and Prognostic Biomarker in Chronic Obstructive Pulmonary Disease Exacerbations: A Literature Review Update.
P2860
Q33505806-42CD199C-7A7C-4C5F-AF1A-5F2145CA14F7Q35493256-F6F41109-9F56-467A-955A-F77758BD3087Q37521971-C7342DE5-C24C-47F0-B131-F913984FE2BAQ38201309-F366F98C-3C29-4458-8DDE-F775DE66DFA9Q38503383-47A58A79-00C7-42D3-94FA-12A7FB129FC9Q38649675-001514F6-40FF-42D3-9AC8-EB5743165BE2Q39558643-CD96BA5E-F2BB-48CC-9D43-9348B98E74DDQ40114391-E8D52D7C-4D38-4429-B484-16A91DE47F92Q40159607-69FB305B-4A97-4EF4-AF91-E392CC45D8D6Q41546375-06B0A653-2507-4C3E-9360-0691F6E882EBQ43105512-6203B9C5-D4EC-4E91-85AF-A1C519A3DF0AQ44080564-E27DE8C9-C3DE-4092-B3F5-5A00DB06C3B7Q53064513-A189C79A-9CBB-4B8F-AD09-6BB72F60BC21Q55001367-5BF6CA37-8FCE-4002-A8AF-60E831DFE873Q55282489-80295C98-6E3E-4979-995F-5C8D2283281F
P2860
Procalcitonin levels in acute exacerbation of COPD admitted in ICU: a prospective cohort study.
description
2008 nî lūn-bûn
@nan
2008 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Procalcitonin levels in acute ...... U: a prospective cohort study.
@ast
Procalcitonin levels in acute ...... U: a prospective cohort study.
@en
type
label
Procalcitonin levels in acute ...... U: a prospective cohort study.
@ast
Procalcitonin levels in acute ...... U: a prospective cohort study.
@en
prefLabel
Procalcitonin levels in acute ...... U: a prospective cohort study.
@ast
Procalcitonin levels in acute ...... U: a prospective cohort study.
@en
P2093
P2860
P356
P1476
Procalcitonin levels in acute ...... U: a prospective cohort study.
@en
P2093
Astrid Vabret
Cédric Daubin
Damien du Cheyron
François Freymuth
Michel Ramakers
Nicolas Terzi
Pierre Charbonneau
Sabine Fradin
P2860
P2888
P356
10.1186/1471-2334-8-145
P577
2008-10-23T00:00:00Z
P5875
P6179
1008118041